We are live on ! Find out more
VIVS

VivoSim Labs
VIVS

26 hedge funds and large institutions have $110K invested in VivoSim Labs in 2026 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 5 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 3

8% more funds holding

Funds holding: 24 → 26 (+2)

0.21% more ownership

Funds ownership: 3.75% → 3.96% (+0.21%)

22% less capital invested

Capital invested by funds: $140K → $110K (-$30.3K)

60% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 5

Holders
26
Holders Change
+2
Holders Change %
+8.33%
% of All Funds
0.31%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
2
Reduced
5
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$24.9K
2
HF
HRT Financial
New York
+$24.6K
3
TRCT
Tower Research Capital (TRC)
New York
+$3.95K
4
FIA
FNY Investment Advisers
New York
+$269
5
CIAM
Caitong International Asset Management
Hong Kong
+$19

Top Sellers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
-$23K
2
Geode Capital Management
Geode Capital Management
Massachusetts
-$14.6K
3
Citigroup
Citigroup
New York
-$9.3K
4
UBS Group
UBS Group
Switzerland
-$1.25K
5
AF
Allworth Financial
California
-$298

VIVS Hedge Fund Activity: Q2 2026 in Review

26 of the 8,305 institutional investors tracked by Wall St. Rank reported a position in VivoSim Labs (VIVS) for Q2 2026, worth a combined $110K — down 22% from $140K a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new VIVS positions and 3 closed out — a net gain of 2 holders — while 2 added to existing stakes and 5 trimmed.

The largest buyer was Renaissance Technologies, opening a new position worth an estimated $24.9K. The largest seller was Goldman Sachs, exiting entirely with an estimated $23K sold.

  • 26 institutional investors held VivoSim Labs (VIVS) as of Q2 2026, up from 24 in Q1 2026.
  • Funds reported $110K of VivoSim Labs stock for Q2 2026, down 22% quarter-over-quarter.
  • 5 funds opened new VivoSim Labs positions in Q2 2026 and 3 closed out, a net change of +2 holders.
  • The largest VivoSim Labs buyer in Q2 2026 was Renaissance Technologies, an estimated $24.9K added.
  • The largest VivoSim Labs seller in Q2 2026 was Goldman Sachs, an estimated $23K sold.

Based on aggregated 13F filings for Q2 2026.